Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $980,280 - $1.88 Million
50,400 Added 7200.0%
51,100 $993,000
Q1 2024

May 15, 2024

SELL
$36.08 - $54.3 $169,576 - $255,210
-4,700 Reduced 87.04%
700 $26,000
Q4 2023

Feb 14, 2024

SELL
$34.32 - $57.55 $17,160 - $28,775
-500 Reduced 8.47%
5,400 $302,000
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $122,580 - $188,940
-3,000 Reduced 33.71%
5,900 $243,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $341,432 - $393,424
6,700 Added 304.55%
8,900 $496,000
Q1 2023

May 15, 2023

SELL
$35.33 - $55.79 $127,188 - $200,844
-3,600 Reduced 62.07%
2,200 $122,000
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $141,520 - $239,539
5,800 New
5,800 $211,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.49B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.